Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0
These joint practice guidelines, or procedure standards, were developed collaboratively by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neurooncology (EANO), and the working group for Response Assessme...
Saved in:
| Published in | European journal of nuclear medicine and molecular imaging Vol. 46; no. 3; pp. 540 - 557 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.03.2019
Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1619-7070 1619-7089 |
| DOI | 10.1007/s00259-018-4207-9 |
Cover
| Abstract | These joint practice guidelines, or procedure standards, were developed collaboratively by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neurooncology (EANO), and the working group for Response Assessment in Neurooncology with PET (PET-RANO). Brain PET imaging is being increasingly used to supplement MRI in the clinical management of glioma. The aim of these standards/guidelines is to assist nuclear medicine practitioners in recommending, performing, interpreting and reporting the results of brain PET imaging in patients with glioma to achieve a high-quality imaging standard for PET using FDG and the radiolabelled amino acids MET, FET and FDOPA. This will help promote the appropriate use of PET imaging and contribute to evidence-based medicine that may improve the diagnostic impact of this technique in neurooncological practice. The present document replaces a former version of the guidelines published in 2006 (Vander Borght et al. Eur J Nucl Med Mol Imaging. 33:1374–80,
2006
), and supplements a recent evidence-based recommendation by the PET-RANO working group and EANO on the clinical use of PET imaging in patients with glioma (Albert et al. Neuro Oncol. 18:1199–208,
2016
). The information provided should be taken in the context of local conditions and regulations. |
|---|---|
| AbstractList | These joint practice guidelines, or procedure standards, were developed collaboratively by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neurooncology (EANO), and the working group for Response Assessment in Neurooncology with PET (PET-RANO). Brain PET imaging is being increasingly used to supplement MRI in the clinical management of glioma. The aim of these standards/guidelines is to assist nuclear medicine practitioners in recommending, performing, interpreting and reporting the results of brain PET imaging in patients with glioma to achieve a high-quality imaging standard for PET using FDG and the radiolabelled amino acids MET, FET and FDOPA. This will help promote the appropriate use of PET imaging and contribute to evidence-based medicine that may improve the diagnostic impact of this technique in neurooncological practice. The present document replaces a former version of the guidelines published in 2006 (Vander Borght et al. Eur J Nucl Med Mol Imaging. 33:1374–80,
2006
), and supplements a recent evidence-based recommendation by the PET-RANO working group and EANO on the clinical use of PET imaging in patients with glioma (Albert et al. Neuro Oncol. 18:1199–208,
2016
). The information provided should be taken in the context of local conditions and regulations. These joint practice guidelines, or procedure standards, were developed collaboratively by the European Association of Nuclear Medicine (EANM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Neurooncology (EANO), and the working group for Response Assessment in Neurooncology with PET (PET-RANO). Brain PET imaging is being increasingly used to supplement MRI in the clinical management of glioma. The aim of these standards/guidelines is to assist nuclear medicine practitioners in recommending, performing, interpreting and reporting the results of brain PET imaging in patients with glioma to achieve a high-quality imaging standard for PET using FDG and the radiolabelled amino acids MET, FET and FDOPA. This will help promote the appropriate use of PET imaging and contribute to evidence-based medicine that may improve the diagnostic impact of this technique in neurooncological practice. The present document replaces a former version of the guidelines published in 2006 (Vander Borght et al. Eur J Nucl Med Mol Imaging. 33:1374-80, 2006), and supplements a recent evidence-based recommendation by the PET-RANO working group and EANO on the clinical use of PET imaging in patients with glioma (Albert et al. Neuro Oncol. 18:1199-208, 2016). The information provided should be taken in the context of local conditions and regulations. |
| Author | Law, Ian Drzezga, Alexander Lopci, Egesta Sattler, Bernhard Quick, Harald H. Tonn, Jörg-Christian Langen, Karl-Josef Weller, Michael Galldiks, Norbert Schuster, David M. Arbizu, Javier McConathy, Jonathan Lowe, Val Boellaard, Ronald Albert, Nathalie L. la Fougère, Christian |
| Author_xml | – sequence: 1 givenname: Ian orcidid: 0000-0001-9644-7496 surname: Law fullname: Law, Ian email: ilaw@dadlnet.dk organization: Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, University of Copenhagen – sequence: 2 givenname: Nathalie L. surname: Albert fullname: Albert, Nathalie L. organization: Department of Nuclear Medicine, Ludwig-Maximilians-University – sequence: 3 givenname: Javier surname: Arbizu fullname: Arbizu, Javier organization: Department of Nuclear Medicine, Clínica Universidad de Navarra, University of Navarre – sequence: 4 givenname: Ronald surname: Boellaard fullname: Boellaard, Ronald organization: Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Department of Radiology and Nuclear Medicine, VU University Medical Center – sequence: 5 givenname: Alexander surname: Drzezga fullname: Drzezga, Alexander organization: Department of Nuclear Medicine, University Hospital Cologne – sequence: 6 givenname: Norbert surname: Galldiks fullname: Galldiks, Norbert organization: Department of Neurology, University Hospital Cologne, Institute of Neuroscience and Medicine (INM-3, -4), Forschungszentrum Julich – sequence: 7 givenname: Christian surname: la Fougère fullname: la Fougère, Christian organization: Division of Nuclear Medicine and Clinical Molecular Imaging, Department of Radiology, University of Tübingen – sequence: 8 givenname: Karl-Josef surname: Langen fullname: Langen, Karl-Josef organization: Institute of Neuroscience and Medicine (INM-3, -4), Forschungszentrum Julich, Department of Nuclear Medicine, RWTH University Aachen – sequence: 9 givenname: Egesta surname: Lopci fullname: Lopci, Egesta organization: Department of Nuclear Medicine, Humanitas Clinical and Research Hospital – sequence: 10 givenname: Val surname: Lowe fullname: Lowe, Val organization: Department of Radiology, Nuclear Medicine, Mayo Clinic – sequence: 11 givenname: Jonathan surname: McConathy fullname: McConathy, Jonathan organization: Division of Molecular Imaging and Therapeutics, University of Alabama at Birmingham – sequence: 12 givenname: Harald H. surname: Quick fullname: Quick, Harald H. organization: High-Field and Hybrid MR Imaging, University Hospital Essen – sequence: 13 givenname: Bernhard surname: Sattler fullname: Sattler, Bernhard organization: Department for Nuclear Medicine, University Hospital Leipzig – sequence: 14 givenname: David M. surname: Schuster fullname: Schuster, David M. organization: Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University – sequence: 15 givenname: Jörg-Christian surname: Tonn fullname: Tonn, Jörg-Christian organization: Department of Neurosurgery, Ludwig-Maximilians-University Munich – sequence: 16 givenname: Michael surname: Weller fullname: Weller, Michael organization: Department of Neurology, University Hospital Zurich |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30519867$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9UctuFDEQtFAQecAHcEGWOE_W9jzNASkKuyEomyAIJ4SsHrtn4mjW3tgzQfwLH4tXG5aHBJe21V1VXXYdkj3nHRLynLNjzlg9i4yJUmaMN1khWJ3JR-SAV1xmNWvk3u5es31yGOMtS0DRyCdkP2cll01VH5Dv77x1I52fXC5nqVzNPqRC1wH0aDXSfrIGB-swzj5eLpfnaeI1mikgjSM4A8FE2vlA7Qp663rqO9oP1q8g0iluGu_n1_SrHW9oAGP9AC0OAxoKK-s8BW0TP-nQz7xZfFm8OXtF7zFE6x3lx-wpedzBEPHZw3lEPi3m16dvs4urs_PTk4tMF005ZqJo8kqzAnjRcDRFxVAK2Yi6FQBVbmpssasATIG5Nq0RLbCqZgXHrgWZ8_yIvN7qrqd2hUajGwMMah3Sq8I35cGqPyfO3qje36sqL3nJ8yTw8kEg-LsJ46hu_RRc8qwEL5nIq-QnoV78vman_zONBOBbgA4-xoDdDsKZ2iSutomrFKTaJK5k4tR_cbQdYUw_mJza4b9MsWXGtMX1GH6Z_jfpB6ypv7s |
| CitedBy_id | crossref_primary_10_1016_j_remnie_2023_10_003 crossref_primary_10_3389_fnume_2023_1103262 crossref_primary_10_1186_s13014_022_02146_8 crossref_primary_10_1007_s11060_021_03873_w crossref_primary_10_1007_s40336_022_00516_6 crossref_primary_10_1016_j_ejrad_2020_109021 crossref_primary_10_1007_s00259_021_05526_6 crossref_primary_10_1016_j_critrevonc_2020_103184 crossref_primary_10_1007_s13139_022_00758_2 crossref_primary_10_1016_j_critrevonc_2020_103188 crossref_primary_10_1016_S1470_2045_23_00453_9 crossref_primary_10_1053_j_semnuclmed_2019_06_001 crossref_primary_10_1126_sciadv_adi8986 crossref_primary_10_1007_s00259_021_05530_w crossref_primary_10_3390_cancers16142581 crossref_primary_10_1259_bjr_20200095 crossref_primary_10_1093_noajnl_vdz010 crossref_primary_10_1007_s00259_019_04384_7 crossref_primary_10_1053_j_sult_2021_07_002 crossref_primary_10_3389_fonc_2021_735388 crossref_primary_10_1016_j_neuroimage_2020_117221 crossref_primary_10_1053_j_semnuclmed_2024_09_004 crossref_primary_10_3390_jcm14072168 crossref_primary_10_1007_s11307_022_01769_3 crossref_primary_10_3390_molecules25061471 crossref_primary_10_3390_diagnostics13101813 crossref_primary_10_1007_s00062_022_01139_0 crossref_primary_10_1007_s00259_023_06505_9 crossref_primary_10_1007_s40336_020_00398_6 crossref_primary_10_1007_s00259_022_05917_3 crossref_primary_10_1016_S1470_2045_23_00525_9 crossref_primary_10_1186_s40658_022_00438_2 crossref_primary_10_3390_diagnostics13152604 crossref_primary_10_1080_14737175_2023_2285472 crossref_primary_10_3389_fnume_2022_960820 crossref_primary_10_1158_1078_0432_CCR_21_0471 crossref_primary_10_3390_diagnostics12071665 crossref_primary_10_1177_1536012120968669 crossref_primary_10_3390_cancers14010053 crossref_primary_10_1080_14737175_2020_1704256 crossref_primary_10_1093_neuonc_noae049 crossref_primary_10_3390_cancers12092629 crossref_primary_10_1007_s11307_020_01472_1 crossref_primary_10_1097_RLU_0000000000004185 crossref_primary_10_3389_fmed_2022_945602 crossref_primary_10_1007_s00259_023_06225_0 crossref_primary_10_1007_s00259_024_06720_y crossref_primary_10_3390_cancers12113080 crossref_primary_10_3389_fneur_2021_671867 crossref_primary_10_1016_j_neurol_2023_03_002 crossref_primary_10_1186_s13550_024_01119_0 crossref_primary_10_3390_jcm11206065 crossref_primary_10_1007_s00330_022_09221_4 crossref_primary_10_1038_s41598_021_04216_5 crossref_primary_10_3389_fmed_2024_1347267 crossref_primary_10_1007_s11864_021_00875_8 crossref_primary_10_3390_jcm10112313 crossref_primary_10_3390_cancers14194860 crossref_primary_10_1097_WCO_0000000000000841 crossref_primary_10_1186_s40644_022_00454_6 crossref_primary_10_1007_s13139_024_00894_x crossref_primary_10_1007_s00259_024_06654_5 crossref_primary_10_3390_ijms22084159 crossref_primary_10_1007_s11060_020_03613_6 crossref_primary_10_3390_biomedicines12040789 crossref_primary_10_1080_0284186X_2020_1787507 crossref_primary_10_1007_s00330_020_07470_9 crossref_primary_10_1007_s00259_022_06105_z crossref_primary_10_1016_j_critrevonc_2021_103230 crossref_primary_10_3389_fimmu_2022_852811 crossref_primary_10_1016_j_radonc_2024_110594 crossref_primary_10_1007_s11060_021_03701_1 crossref_primary_10_1007_s00259_022_05988_2 crossref_primary_10_1007_s11940_021_00664_6 crossref_primary_10_2967_jnumed_119_227231 crossref_primary_10_1007_s40336_021_00416_1 crossref_primary_10_3389_fonc_2022_829050 crossref_primary_10_1093_noajnl_vdae210 crossref_primary_10_1097_RLU_0000000000005058 crossref_primary_10_1007_s11912_021_01020_2 crossref_primary_10_3389_fmed_2021_705996 crossref_primary_10_3389_fonc_2021_645316 crossref_primary_10_24835_1607_0763_1170 crossref_primary_10_3390_cancers15143577 crossref_primary_10_1097_RLU_0000000000005174 crossref_primary_10_1016_j_zemedi_2022_12_005 crossref_primary_10_1093_neuonc_noaa106 crossref_primary_10_1158_1078_0432_CCR_23_3842 crossref_primary_10_3390_cancers14143336 crossref_primary_10_1038_s41598_021_00193_x crossref_primary_10_1186_s41824_021_00101_6 crossref_primary_10_3390_brainsci12111426 crossref_primary_10_1016_j_critrevonc_2023_104114 crossref_primary_10_1186_s13550_020_00645_x crossref_primary_10_1097_RLU_0000000000003507 crossref_primary_10_1016_j_radonc_2024_110386 crossref_primary_10_1093_neuonc_noae078 crossref_primary_10_1053_j_semnuclmed_2021_11_012 crossref_primary_10_3390_biomedicines9121924 crossref_primary_10_3390_diagnostics12051202 crossref_primary_10_2967_jnumed_118_220293 crossref_primary_10_3389_fonc_2021_811425 crossref_primary_10_2967_jnumed_122_264859 crossref_primary_10_3390_cancers13020355 crossref_primary_10_1093_neuonc_noz147 crossref_primary_10_1093_neuros_nyz199 crossref_primary_10_3389_fneur_2022_822362 crossref_primary_10_1038_s41582_021_00510_y crossref_primary_10_3390_cancers13040647 crossref_primary_10_1007_s00259_022_05817_6 crossref_primary_10_1259_bjro_20190033 crossref_primary_10_26442_00403660_2021_04_200673 crossref_primary_10_2967_jnumed_122_265149 crossref_primary_10_1097_RLU_0000000000002890 crossref_primary_10_1016_j_nucmedbio_2020_02_006 crossref_primary_10_3389_fonc_2021_772703 crossref_primary_10_1007_s11060_021_03844_1 crossref_primary_10_1155_2021_8874078 crossref_primary_10_1053_j_semnuclmed_2024_01_010 crossref_primary_10_1097_RLU_0000000000003735 crossref_primary_10_1016_j_cpet_2022_03_004 crossref_primary_10_3390_s24092865 crossref_primary_10_1007_s40336_022_00507_7 crossref_primary_10_1016_j_cpet_2022_03_002 crossref_primary_10_1007_s12149_020_01442_1 crossref_primary_10_1007_s40336_024_00646_z crossref_primary_10_1093_noajnl_vdac137 crossref_primary_10_3390_cancers14092163 crossref_primary_10_1016_j_ctarc_2022_100583 crossref_primary_10_1093_neuonc_noab013 crossref_primary_10_1097_MNM_0000000000001294 crossref_primary_10_3174_ajnr_A6358 crossref_primary_10_1016_j_currproblcancer_2023_100965 crossref_primary_10_23736_S1824_4785_24_03587_8 crossref_primary_10_3390_cancers15020364 crossref_primary_10_2967_jnumed_124_268768 crossref_primary_10_1093_neuonc_noac229 crossref_primary_10_3390_cancers13194777 crossref_primary_10_3390_cancers11020153 crossref_primary_10_1007_s00415_020_10269_9 crossref_primary_10_3389_fnume_2023_1183471 crossref_primary_10_1016_j_jocn_2025_111037 crossref_primary_10_1158_0008_5472_CAN_19_1169 crossref_primary_10_3390_curroncol28040226 crossref_primary_10_2967_jnumed_119_238568 crossref_primary_10_1007_s11604_019_00901_8 crossref_primary_10_1007_s11060_023_04534_w crossref_primary_10_3390_diagnostics10121049 crossref_primary_10_1053_j_semnuclmed_2020_08_003 crossref_primary_10_2967_jnumed_123_265647 crossref_primary_10_1007_s00259_021_05603_w crossref_primary_10_1007_s11060_024_04722_2 crossref_primary_10_1002_jmri_28663 crossref_primary_10_1097_RLU_0000000000002790 crossref_primary_10_1007_s12149_024_01911_x crossref_primary_10_2967_jnumed_123_266853 crossref_primary_10_1007_s00259_023_06330_0 crossref_primary_10_1097_RLU_0000000000005023 crossref_primary_10_1007_s00259_018_4166_1 crossref_primary_10_1136_bmjopen_2022_071327 crossref_primary_10_1016_j_radonc_2020_06_040 crossref_primary_10_1111_1754_9485_13322 crossref_primary_10_1097_PPO_0000000000000716 crossref_primary_10_1158_1078_0432_CCR_23_0009 crossref_primary_10_1016_j_ctro_2023_100706 crossref_primary_10_1016_j_wneu_2021_01_012 crossref_primary_10_3390_biomedicines13030657 crossref_primary_10_1016_j_nec_2020_08_003 crossref_primary_10_17116_neiro2021850315 crossref_primary_10_2967_jnumed_119_234757 crossref_primary_10_3389_fonc_2022_939260 crossref_primary_10_1093_neuonc_noaa023 crossref_primary_10_1093_noajnl_vdaa054 crossref_primary_10_1097_MD_0000000000019017 crossref_primary_10_1093_noajnl_vdaa050 crossref_primary_10_1007_s11060_023_04529_7 crossref_primary_10_1093_noajnl_vdaa172 crossref_primary_10_1186_s12880_022_00952_w crossref_primary_10_1007_s11912_023_01440_2 crossref_primary_10_1097_RLU_0000000000002610 crossref_primary_10_22328_2079_5343_2021_12_1_49_58 crossref_primary_10_3389_fonc_2021_721821 crossref_primary_10_1007_s00259_023_06437_4 crossref_primary_10_1007_s40134_020_00366_y crossref_primary_10_3390_cancers15010098 crossref_primary_10_1016_j_mric_2023_06_004 crossref_primary_10_2214_AJR_19_22571 crossref_primary_10_1093_neuonc_noac131 crossref_primary_10_1038_s41598_019_50182_4 crossref_primary_10_1088_1742_6596_2058_1_012038 crossref_primary_10_1007_s12149_024_01973_x crossref_primary_10_1186_s41181_019_0058_3 crossref_primary_10_1007_s00259_023_06426_7 crossref_primary_10_2967_jnumed_120_261545 crossref_primary_10_1093_neuonc_noad228 crossref_primary_10_1259_bjr_20200810 crossref_primary_10_1093_nop_npaa065 crossref_primary_10_3390_ijms20194669 crossref_primary_10_23736_S0390_5616_20_04982_6 crossref_primary_10_1007_s00330_022_08606_9 crossref_primary_10_1093_neuonc_noz083 crossref_primary_10_3389_fonc_2021_699360 crossref_primary_10_1016_j_remnie_2020_10_011 crossref_primary_10_1259_bjro_20200009 crossref_primary_10_52560_2713_0118_2021_4_34_48 crossref_primary_10_1186_s12916_024_03831_z crossref_primary_10_1136_bmjopen_2022_062555 crossref_primary_10_1016_j_radonc_2024_110616 crossref_primary_10_1148_radiol_223016 crossref_primary_10_1007_s40336_022_00509_5 crossref_primary_10_1186_s40658_021_00379_2 crossref_primary_10_1259_bjr_20211018 crossref_primary_10_1007_s00066_022_01994_3 crossref_primary_10_3390_cancers15010083 crossref_primary_10_1093_noajnl_vdab003 crossref_primary_10_1186_s13550_024_01164_9 crossref_primary_10_3174_ajnr_A7762 crossref_primary_10_3390_cancers15010090 crossref_primary_10_3390_cancers16010195 crossref_primary_10_2967_jnumed_122_264803 crossref_primary_10_1007_s00259_024_06783_x crossref_primary_10_3390_cancers14235765 crossref_primary_10_1002_pbc_30150 crossref_primary_10_1109_TMI_2021_3067169 crossref_primary_10_1186_s40644_019_0241_5 crossref_primary_10_1007_s13139_024_00847_4 crossref_primary_10_2967_jnumed_123_265725 crossref_primary_10_17116_neiro20248801163 crossref_primary_10_1016_j_nicl_2024_103616 crossref_primary_10_1055_a_1712_6180 crossref_primary_10_1007_s00062_023_01372_1 crossref_primary_10_1111_ene_16093 crossref_primary_10_1007_s00259_019_04656_2 crossref_primary_10_3389_fnins_2023_1142383 crossref_primary_10_1097_RLU_0000000000005346 crossref_primary_10_3390_cancers16030576 crossref_primary_10_1093_neuonc_noz166 crossref_primary_10_1002_nbm_4719 crossref_primary_10_1007_s00259_023_06562_0 crossref_primary_10_2967_jnumed_124_268754 crossref_primary_10_3390_cancers16030575 crossref_primary_10_2967_jnmt_121_263050 crossref_primary_10_1007_s11307_019_01357_y crossref_primary_10_1007_s40336_022_00501_z crossref_primary_10_1097_MNM_0000000000001623 crossref_primary_10_1007_s40336_022_00523_7 crossref_primary_10_2967_jnmt_122_263905 crossref_primary_10_3390_cancers16020407 crossref_primary_10_1016_j_wneu_2021_04_076 crossref_primary_10_1007_s00259_021_05352_w crossref_primary_10_1093_noajnl_vdae178 crossref_primary_10_22328_2079_5343_2019_10_3_42_52 crossref_primary_10_1007_s00381_024_06573_8 crossref_primary_10_1093_noajnl_vdae056 crossref_primary_10_1007_s00259_019_04509_y crossref_primary_10_3390_diagnostics14141551 crossref_primary_10_1097_RLU_0000000000004435 crossref_primary_10_3390_cancers16071265 crossref_primary_10_1007_s12149_024_02005_4 crossref_primary_10_3389_fnume_2024_1287240 crossref_primary_10_1016_j_neurad_2020_08_003 crossref_primary_10_1186_s13550_024_01158_7 crossref_primary_10_1007_s00259_023_06308_y crossref_primary_10_1038_s41598_024_53693_x crossref_primary_10_2967_jnumed_120_254243 crossref_primary_10_1007_s00330_022_09043_4 crossref_primary_10_1093_noajnl_vdaa119 crossref_primary_10_1097_MNM_0000000000001795 crossref_primary_10_3390_curroncol28060444 crossref_primary_10_3390_cancers13215340 crossref_primary_10_3389_fmed_2023_1300179 crossref_primary_10_3390_ph17091228 crossref_primary_10_1007_s00259_020_04695_0 crossref_primary_10_1371_journal_pone_0232141 crossref_primary_10_1016_j_ebiom_2024_105068 crossref_primary_10_1016_S1634_7072_19_43056_0 crossref_primary_10_1007_s00259_023_06406_x crossref_primary_10_3174_ajnr_A8243 crossref_primary_10_1007_s10143_020_01448_3 crossref_primary_10_3390_cancers14153771 crossref_primary_10_3389_fneur_2021_634609 crossref_primary_10_1007_s00115_019_0716_4 crossref_primary_10_1007_s00259_022_06006_1 crossref_primary_10_1097_RLU_0000000000005634 crossref_primary_10_3390_diagnostics12102331 crossref_primary_10_1007_s00259_024_07038_5 crossref_primary_10_1007_s11060_022_04201_6 crossref_primary_10_1016_j_remn_2020_10_011 crossref_primary_10_3389_fnmol_2019_00151 crossref_primary_10_1007_s11307_021_01679_w crossref_primary_10_1097_MNM_0000000000001202 crossref_primary_10_3390_cancers13092093 crossref_primary_10_1093_neuonc_noad154 crossref_primary_10_3390_tomography8040170 crossref_primary_10_7326_aimcc_2024_0569 crossref_primary_10_1007_s00259_019_4276_4 crossref_primary_10_1093_neuonc_noab096 crossref_primary_10_1007_s00259_023_06367_1 crossref_primary_10_1007_s00259_019_04333_4 crossref_primary_10_3390_ph17091215 crossref_primary_10_23736_S1824_4785_20_03267_7 crossref_primary_10_3390_ijms26030917 crossref_primary_10_1007_s40134_019_0324_x crossref_primary_10_2967_jnumed_119_233809 crossref_primary_10_1016_j_mednuc_2022_12_003 crossref_primary_10_1097_RLU_0000000000005197 crossref_primary_10_1097_RLU_0000000000003331 crossref_primary_10_3389_fonc_2022_892056 crossref_primary_10_1016_j_hoc_2021_08_002 crossref_primary_10_1007_s11060_022_04177_3 crossref_primary_10_1007_s13311_022_01251_6 crossref_primary_10_1186_s41824_024_00189_6 crossref_primary_10_1055_s_0043_1777729 crossref_primary_10_1093_neuonc_noac040 crossref_primary_10_1007_s00330_021_07756_6 crossref_primary_10_1080_14737140_2020_1705788 crossref_primary_10_1007_s11060_022_04089_2 crossref_primary_10_3390_diagnostics14101002 crossref_primary_10_1007_s11060_021_03730_w crossref_primary_10_2967_jnumed_121_262051 crossref_primary_10_3389_fonc_2021_774017 crossref_primary_10_3390_s23249842 crossref_primary_10_1016_j_rcl_2021_05_013 crossref_primary_10_1007_s00259_023_06468_x crossref_primary_10_1093_noajnl_vdac080 crossref_primary_10_1186_s41983_023_00731_6 crossref_primary_10_1016_j_mednuc_2020_02_006 crossref_primary_10_1097_RLU_0000000000004329 crossref_primary_10_1007_s00259_024_06656_3 crossref_primary_10_1007_s13139_024_00899_6 crossref_primary_10_1016_j_remn_2023_08_004 crossref_primary_10_1007_s11060_023_04438_9 crossref_primary_10_2174_1874471012666190111111046 crossref_primary_10_1093_nop_npab027 crossref_primary_10_1007_s40336_022_00503_x crossref_primary_10_3390_cancers13010047 crossref_primary_10_3390_jcm13206252 crossref_primary_10_1007_s00330_023_10141_0 crossref_primary_10_1016_j_cpet_2024_09_003 crossref_primary_10_3390_cancers14051103 crossref_primary_10_1007_s00259_023_06114_6 crossref_primary_10_3390_cancers11121853 crossref_primary_10_3390_diagnostics13243610 crossref_primary_10_1007_s00259_024_06782_y crossref_primary_10_1053_j_semnuclmed_2021_03_003 crossref_primary_10_1186_s40644_020_00348_5 crossref_primary_10_1039_D0CP01938K crossref_primary_10_3389_fonc_2021_735257 crossref_primary_10_2967_jnumed_120_248278 |
| Cites_doi | 10.1186/s40658-015-0112-5 10.1007/s00259-007-0370-0 10.1186/s40658-014-0101-0 10.1007/s00259-009-1264-0 10.1007/s00259-014-2959-4 10.4103/0028-3886.15076 10.1093/neuonc/not166 10.1016/j.cpet.2015.03.011 10.1007/s10334-012-0347-2 10.2967/jnumed.111.098590 10.1007/s11307-007-0115-2 10.1016/j.ejrad.2013.06.033 10.2967/jnumed.116.176610 10.1158/1078-0432.CCR-13-1440 10.3174/ajnr.A3173 10.1016/j.nucmedbio.2006.09.004 10.1177/0146645314558019 10.1007/s00259-017-3741-1 10.1097/RLU.0000000000001189 10.1007/s00259-010-1457-6 10.1007/s00259-017-3619-2 10.1186/s40658-016-0169-9 10.1093/neuonc/nox153 10.2967/jnumed.112.109603 10.2967/jnumed.113.123836 10.1016/j.radonc.2012.04.022 10.2214/AJR.12.9168 10.1023/A:1026518002800 10.1007/s00259-013-2512-x 10.1097/RLI.0000000000000131 10.3174/ajnr.A3324 10.1038/nrneurol.2017.44 10.1186/s13550-017-0295-y 10.1093/neuonc/nos259 10.1016/j.wneu.2016.01.085 10.2967/jnumed.115.166967 10.2967/jnumed.106.037689 10.1007/s002590050597 10.1007/s00259-014-2961-x 10.2967/jnumed.107.048082 10.1093/neuonc/not002 10.1097/MNM.0000000000000236 10.1007/s11060-015-1883-1 10.1007/s00259-009-1297-4 10.1007/s00330-015-3691-6 10.2967/jnumed.109.071423 10.2310/7290.2012.00027 10.1093/neuonc/nov118 10.1161/01.STR.26.10.1859 10.3413/Nukmed-0347-10-09 10.1016/S1470-2045(17)30194-8 10.1093/neuonc/nos012 10.1161/STROKEAHA.108.536037 10.1007/BF02988258 10.1016/j.neuroimage.2016.12.010 10.1200/JCO.2009.26.3541 10.1016/S1470-2045(15)00088-1 10.1186/s13550-017-0316-x 10.1016/0303-8467(95)00067-T 10.3389/fnins.2017.00453 10.1007/s00259-009-1347-y 10.1093/neuonc/nov189 10.2967/jnumed.116.183343 10.2967/jnumed.110.086645 10.1016/j.neuroimage.2013.08.042 10.1016/j.clineuro.2014.08.004 10.1097/RLU.0b013e318292a753 10.1093/neuonc/now058 10.1007/s00259-009-1219-5 10.1016/j.ejrad.2011.01.080 10.1177/135245859700300102 10.1093/neuonc/nou286 10.1007/s00259-006-0206-3 10.1093/brain/awh399 10.1007/s00401-016-1545-1 10.1007/s00259-017-3618-3 10.1007/s00259-015-3276-2 10.1158/1078-0432.CCR-15-1334 10.1007/s00259-012-2251-4 10.1007/s11307-017-1123-5 10.1212/WNL.50.5.1316 10.1038/nrneurol.2016.80 10.1158/1078-0432.CCR-04-0262 10.1007/s00259-005-0002-5 10.1007/s00259-017-3846-6 10.1093/neuonc/nov148 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2018 European Journal of Nuclear Medicine and Molecular Imaging is a copyright of Springer, (2018). All Rights Reserved. © 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2018 – notice: European Journal of Nuclear Medicine and Molecular Imaging is a copyright of Springer, (2018). All Rights Reserved. © 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7TK 7X7 7XB 88E 8AO 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. KB0 LK8 M0S M1P M7P NAPCQ P5Z P62 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 5PM |
| DOI | 10.1007/s00259-018-4207-9 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences ProQuest Health & Medical Collection Medical Database ProQuest Biological Science Nursing & Allied Health Premium Advanced Technologies & Aerospace Collection ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student Technology Collection ProQuest One Academic Middle East (New) ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Advanced Technologies & Aerospace Database Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) |
| DatabaseTitleList | MEDLINE ProQuest Central Student |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1619-7089 |
| EndPage | 557 |
| ExternalDocumentID | PMC6351513 30519867 10_1007_s00259_018_4207_9 |
| Genre | Journal Article |
| GroupedDBID | --- -5E -5G -BR -~C .86 .VR 04C 06C 06D 0R~ 0VY 199 1N0 203 29G 29~ 2JN 2JY 2KM 2LR 2~H 30V 36B 4.4 406 40D 53G 5GY 5RE 5VS 67Z 6NX 78A 7RV 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ 8UJ 95- 95. 95~ 96X AAAVM AACDK AAHNG AAIAL AAJBT AANZL AARTL AASML AATNV AATVU AAUYE AAWCG AAYQN AAYZH ABAKF ABBBX ABBXA ABDBF ABECU ABFTV ABHQN ABIPD ABJNI ABJOX ABKCH ABLJU ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABUWG ABUWZ ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACHVE ACIWK ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACUHS ACZOJ ADBBV ADHIR ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEFQL AEGAL AEGNC AEJRE AEMSY AENEX AEOHA AEPYU AESKC AEVLU AEXYK AFBBN AFJLC AFKRA AFLOW AFQWF AFRAH AFWTZ AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGVAE AGWIL AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARAPS ARMRJ AXYYD AZFZN B-. B0M BA0 BBNVY BDATZ BENPR BGLVJ BGNMA BHPHI BKEYQ BMSDO BPHCQ BSONS BVXVI C6C CCPQU CSCUP DDRTE DL5 DNIVK DPUIP DU5 EAD EAP EAS EBB EBC EBD EBLON EBO EBS EBX EHN EIHBH EIOEI EJD EMB EMK EMOBN EPL EPT ESBYG ESX EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GNWQR GQ6 GQ7 GQ8 GXS HCIFZ HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KPH LK8 LLZTM M1P M4Y M7P MA- N9A NAPCQ NB0 NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P62 P9S PF0 PQQKQ PROAC PSQYO PT4 Q2X QOK QOR QOS Q~Q R89 R9I RNS ROL RPX RRX RSV S27 S37 S3B SAP SDH SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 TH9 TSG TSK TT1 TUS U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WK8 WOW YLTOR Z45 Z7R Z7U Z7W Z7X Z7Y Z7Z Z81 Z82 Z83 Z87 Z88 Z8M Z8O Z8Q Z8R Z8S Z8T Z8U Z8V Z8W Z8Z Z91 ZMTXR ~8M -Y2 .GJ 2P1 2VQ 5QI AANXM AAPKM AARHV AAYTO AAYXX ABBRH ABDBE ABFSG ABQSL ABULA ACBXY ACSTC ACUDM ADHKG AEBTG AEFIE AEKMD AEZWR AFDZB AFEXP AFFNX AFHIU AFOHR AGGDS AGQPQ AHPBZ AHWEU AIXLP AJBLW ATHPR AYFIA CAG CITATION COF EN4 GRRUI H13 LAS N2Q NDZJH OVD PHGZM PHGZT PT5 RNI RZK S1Z S26 S28 SCLPG T16 TEORI 3V. CGR CUY CVF ECM EIF NPM 7TK 7XB 8FK ABRTQ AZQEC DWQXO GNUQQ K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS 5PM |
| ID | FETCH-LOGICAL-c485t-24836c04a1481ed460e929827b2aa63d7ebef6aad4e3cdbd2ba067041efba9313 |
| IEDL.DBID | C6C |
| ISSN | 1619-7070 |
| IngestDate | Thu Aug 21 14:04:42 EDT 2025 Tue Aug 19 06:40:56 EDT 2025 Wed Feb 19 02:29:47 EST 2025 Tue Jul 01 04:04:31 EDT 2025 Thu Apr 24 23:10:09 EDT 2025 Fri Feb 21 02:43:42 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | FDG FDOPA FET Glioma MET PET |
| Language | English |
| License | Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c485t-24836c04a1481ed460e929827b2aa63d7ebef6aad4e3cdbd2ba067041efba9313 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
| ORCID | 0000-0001-9644-7496 |
| OpenAccessLink | https://doi.org/10.1007/s00259-018-4207-9 |
| PMID | 30519867 |
| PQID | 2150236298 |
| PQPubID | 42802 |
| PageCount | 18 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6351513 proquest_journals_2150236298 pubmed_primary_30519867 crossref_primary_10_1007_s00259_018_4207_9 crossref_citationtrail_10_1007_s00259_018_4207_9 springer_journals_10_1007_s00259_018_4207_9 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2019-03-01 |
| PublicationDateYYYYMMDD | 2019-03-01 |
| PublicationDate_xml | – month: 03 year: 2019 text: 2019-03-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Berlin/Heidelberg |
| PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
| PublicationTitle | European journal of nuclear medicine and molecular imaging |
| PublicationTitleAbbrev | Eur J Nucl Med Mol Imaging |
| PublicationTitleAlternate | Eur J Nucl Med Mol Imaging |
| PublicationYear | 2019 |
| Publisher | Springer Berlin Heidelberg Springer Nature B.V |
| Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer Nature B.V |
| References | Lopci, Bello, Chiti (CR89) 2014; 33 Salber, Stoffels, Pauleit, Reifenberger, Sabel, Shah (CR82) 2006; 33 Galldiks, Stoffels, Filss, Rapp, Blau, Tscherpel (CR51) 2015; 17 Choi, Bang, Cheon, Kim, Park, Park (CR42) 2015; 36 Andersen, Ladefoged, Beyer, Keller, Hansen, Højgaard (CR19) 2014; 84 Lohmann, Herzog, Rota Kops, Stoffels, Judov, Filss (CR47) 2015; 25 Koesters, Friedman, Fenchel, Zhan, Hermosillo, Babb (CR16) 2016; 57 CR37 Tsuyuguchi, Sunada, Ohata, Takami, Nishio, Hara (CR76) 2003; 17 Busemann Sokole, Płachcínska, Britten (CR92) 2010; 37 Terakawa, Tsuyuguchi, Iwai, Yamanaka, Higashiyama, Takami (CR52) 2008; 49 Zazulia, Videen, Powers (CR80) 2009; 40 Boellaard, O’Doherty, Weber, Mottaghy, Lonsdale, Stroobants (CR91) 2010; 37 Boellaard, Delgado-Bolton, Oyen, Giammarile, Tatsch, Eschner (CR6) 2015; 42 Hutterer, Ebner, Riemenschneider, Willuweit, McCoy, Egger (CR88) 2017; 58 Sattler, Jochimsen, Barthel, Sommerfeld, Stumpp, Hoffmann (CR93) 2013; 26 Kebir, Fimmers, Galldiks, Schäfer, Mack, Schaub (CR56) 2016; 22 Mattsson, Johansson, Leide Svegborn, Liniecki, Noßke, Riklund (CR95) 2015; 44 Galldiks, Stoffels, Ruge, Rapp, Sabel, Reifenberger (CR54) 2013; 54 Bailey, Pichler, Gückel, Antoch, Barthel, Bhujwalla (CR17) 2018; 20 Ogawa, Hatazawa, Inugami, Murakami, Fujita, Shimosegawa (CR77) 1995; 36 Ladefoged, Law, Anazodo, St Lawrence, Izquierdo-Garcia, Catana (CR20) 2017; 147 Wray, Solnes, Mena, Meoded, Subramaniam (CR71) 2015; 10 Fragoso Costa, Santos, Testanera (CR11) 2017; 44 Nihashi, Dahabreh, Terasawa (CR68) 2013; 200 Albert, Weller, Suchorska, Galldiks, Soffietti, Kim (CR7) 2016; 18 Filss, Albert, Böning, Kops, Suchorska, Stoffels (CR44) 2017; 7 Reardon, Ballman, Buckner, Chang, Ellingson (CR3) 2014; 16 Pichler, Dunzinger, Wurm, Pichler, Weis, Nussbaumer (CR75) 2010; 37 Ladefoged, Hansen, Keller, Holm, Law, Beyer (CR21) 2014; 1 Munk, Tolbod, Hansen, Bogsrud (CR26) 2017; 4 Weller, van den Bent, Tonn, Stupp, Preusser, Cohen-Jonathan-Moyal (CR2) 2017; 18 Morana, Piccardo, Garrè, Cabria, Rossi (CR84) 2016; 41 Galldiks, Langen, Holy, Pinkawa, Stoffels, Nolte (CR57) 2012; 53 Lassmann, Biassoni, Monsieurs, Franzius, Jacobs (CR15) 2007; 34 Louis, Perry, Reifenberger, von Deimling, Figarella-Branger, Cavenee (CR34) 2016; 131 Jacobs (CR81) 1995; 26 Cook, Maisey, Fogelman (CR72) 1999; 26 Jansen, Schwartz, Graute, Eigenbrod, Lutz, Egensperger (CR36) 2012; 14 Niyazi, Schnell, Suchorska, Schwarz, Ganswindt, Geisler (CR40) 2012; 104 Galldiks, Dunkl, Stoffels, Hutterer, Rapp, Sabel (CR55) 2015; 42 Nihashi, Dahabreh, Terasawa (CR67) 2013; 34 Ladefoged, Hansen, Keller, Fischer, Rasmussen, Law (CR22) 2015; 2 Schiepers, Van Hecke, Vandenberghe, Van Oostende, Dupont, Demaerel (CR85) 1997; 3 Varrone, Asenbaum, Vander Borght, Booij, Nobili, Någren (CR13) 2009; 36 Minoshima, Koeppe, Mintun, Berger, Taylor, Frey (CR27) 1993; 34 Rapp, Heinzel, Galldiks, Stoffels, Felsberg, Ewelt (CR45) 2013; 54 Zanotti-Fregonara, Lammertsma, Innis (CR94) 2013; 40 Langen, Bartenstein, Boecker, Brust, Coenen, Drzezga (CR96) 2011; 50 Pauleit, Floeth, Hamacher, Riemenschneider, Reifenberger, Müller (CR32) 2005; 128 Herholz, Holzer, Bauer, Schröder, Voges, Ernestus (CR46) 1998; 50 CR14 Hutterer, Nowosielski, Putzer, Waitz, Tinkhauser, Kostron (CR58) 2011; 52 CR12 Galldiks, Rapp, Stoffels, Fink, Shah, Coenen (CR59) 2013; 40 Floeth, Pauleit, Sabel, Reifenberger, Stoffels, Stummer (CR74) 2006; 47 Vander Borght, Asenbaum, Bartenstein, Halldin, Kapucu, Van Laere (CR10) 2006; 33 Lopci, Riva, Olivari, Raneri, Soffietti, Piccardo (CR38) 2017; 44 Mertens, Acou, Van Hauwe, De Ruyck, Van den Broecke, Kalala (CR64) 2013; 38 Chen (CR70) 2007; 48 Ter Voert, Veit-Haibach, Ahn, Wiesinger, Khalighi, Levin (CR25) 2017; 44 Imani, Boada, Lieberman, Davis, Mountz (CR66) 2014; 83 Novak, Molnar, Lengyel, Tron (CR90) 2005; 53 Okita, Nonaka, Shofuda, Kanematsu, Yoshioka, Kodama (CR41) 2014; 125 Dethy, Manto, Kentos, Konopnicki, Pirotte, Goldman (CR73) 1995; 97 Ladefoged, Andersen, Kjær, Højgaard, Law (CR18) 2017; 11 Law, Borgwardt, Højgaard, von Schulthess (CR83) 2015 Langen, Watts (CR9) 2016; 12 Saito, Maruyama, Muragaki, Tanaka, Nitta, Shinoda (CR39) 2013; 34 De Witte, Lefranc, Levivier, Salmon, Brotchi, Goldman (CR62) 2000; 49 Schwarzenberg, Czernin, Cloughesy, Ellingson, Pope, Grogan (CR29) 2014; 20 Dethy, Goldman, Blecic, Luxen, Levivier, Hildebrand (CR78) 1994; 35 Unterrainer, Vettermann, Brendel, Holzgreve, Lifschitz, Zähringer (CR28) 2017; 7 Herrmann, Czernin, Cloughesy, Lai, Pomykala, Benz (CR53) 2014; 16 Albert, Winkelmann, Suchorska, Wenter, Schmid-Tannwald, Mille (CR48) 2016; 43 Colavolpe, Chinot, Metellus, Mancini, Barrie, Bequet-Boucard (CR61) 2012; 14 Ostrom, Gittleman, Fulop, Liu, Blanda, Kromer (CR1) 2015; 17 Langen, Galldiks, Hattingen, Shah (CR8) 2017; 13 Pafundi, Laack, Youland, Parney, Lowe, Giannini (CR50) 2013; 15 Brendle, Schmidt, Oergel, Bezrukov, Mueller, Schraml (CR23) 2015; 50 Wen, Macdonald, Reardon, Cloughesy, Sorensen, Galanis (CR5) 2010; 28 Galldiks, Ullrich, Schroeter, Fink, Kracht (CR49) 2010; 37 CR63 Dankbaar, Snijders, Robe, Seute, Eppinga, Hendrikse (CR65) 2015; 125 Salber, Stoffels, Oros-Peusquens, Shah, Reifenberger, Hamacher (CR79) 2010; 51 Fuin, Pedemonte, Catalano, Izquierdo-Garcia, Soricelli, Salvatore (CR24) 2017; 58 Kracht, Miletic, Busch, Jacobs, Voges, Hoevels (CR33) 2004; 10 Santra, Kumar, Sharma, Bal, Kumar, Julka (CR69) 2012; 81 Bette, Gempt, Delbridge, Kirschke, Schlegel, Foerster (CR43) 2016; 89 Singhal, Narayanan, Jain, Mukherjee, Mantil (CR86) 2008; 10 Jansen, Suchorska, Schwarz, Eigenbrod, Lutz, Graute (CR87) 2013; 12 Graham, Muzi, Spence, O'Sullivan, Lewellen, Link (CR30) 2002; 43 Suchorska, Giese, Biczok, Unterrainer, Weller, Drexler (CR35) 2018; 20 Okada, Weller, Huang, Finocchiaro, Gilbert, Wick (CR4) 2015; 16 Lucignani, Schmidt, Moresco, Striano, Colombo, Sokoloff (CR31) 1993; 34 Galldiks, Kracht, Burghaus, Thomas, Jacobs, Heiss (CR60) 2006; 33 N Galldiks (4207_CR59) 2013; 40 J Schwarzenberg (4207_CR29) 2014; 20 CN Ladefoged (4207_CR21) 2014; 1 B Suchorska (4207_CR35) 2018; 20 N Galldiks (4207_CR55) 2015; 42 4207_CR12 D Pauleit (4207_CR32) 2005; 128 FW Floeth (4207_CR74) 2006; 47 G Morana (4207_CR84) 2016; 41 4207_CR14 I Law (4207_CR83) 2015 P Lohmann (4207_CR47) 2015; 25 N Galldiks (4207_CR57) 2012; 53 CN Ladefoged (4207_CR18) 2017; 11 B Sattler (4207_CR93) 2013; 26 S Dethy (4207_CR78) 1994; 35 M Niyazi (4207_CR40) 2012; 104 A Jacobs (4207_CR81) 1995; 26 D Salber (4207_CR79) 2010; 51 EEGW Voert Ter (4207_CR25) 2017; 44 T Vander Borght (4207_CR10) 2006; 33 H Okada (4207_CR4) 2015; 16 NL Albert (4207_CR48) 2016; 43 M Rapp (4207_CR45) 2013; 54 R Wray (4207_CR71) 2015; 10 W Chen (4207_CR70) 2007; 48 QT Ostrom (4207_CR1) 2015; 17 M Hutterer (4207_CR58) 2011; 52 K Mertens (4207_CR64) 2013; 38 M Hutterer (4207_CR88) 2017; 58 NL Jansen (4207_CR87) 2013; 12 DA Reardon (4207_CR3) 2014; 16 R Pichler (4207_CR75) 2010; 37 T Koesters (4207_CR16) 2016; 57 E Lopci (4207_CR38) 2017; 44 K Herholz (4207_CR46) 1998; 50 4207_CR63 JW Dankbaar (4207_CR65) 2015; 125 R Boellaard (4207_CR91) 2010; 37 Y Okita (4207_CR41) 2014; 125 KJ Langen (4207_CR9) 2016; 12 N Galldiks (4207_CR54) 2013; 54 E Busemann Sokole (4207_CR92) 2010; 37 LW Kracht (4207_CR33) 2004; 10 C Colavolpe (4207_CR61) 2012; 14 Y Terakawa (4207_CR52) 2008; 49 N Fuin (4207_CR24) 2017; 58 M Lassmann (4207_CR15) 2007; 34 NL Jansen (4207_CR36) 2012; 14 K Herrmann (4207_CR53) 2014; 16 T Singhal (4207_CR86) 2008; 10 P Zanotti-Fregonara (4207_CR94) 2013; 40 KJ Langen (4207_CR8) 2017; 13 T Saito (4207_CR39) 2013; 34 H Choi (4207_CR42) 2015; 36 NL Albert (4207_CR7) 2016; 18 M Weller (4207_CR2) 2017; 18 DH Pafundi (4207_CR50) 2013; 15 N Galldiks (4207_CR60) 2006; 33 DN Louis (4207_CR34) 2016; 131 DL Bailey (4207_CR17) 2018; 20 T Nihashi (4207_CR68) 2013; 200 N Tsuyuguchi (4207_CR76) 2003; 17 KJ Langen (4207_CR96) 2011; 50 4207_CR37 A Santra (4207_CR69) 2012; 81 T Ogawa (4207_CR77) 1995; 36 PY Wen (4207_CR5) 2010; 28 FL Andersen (4207_CR19) 2014; 84 GJ Cook (4207_CR72) 1999; 26 CN Ladefoged (4207_CR22) 2015; 2 MM Graham (4207_CR30) 2002; 43 S Kebir (4207_CR56) 2016; 22 C Schiepers (4207_CR85) 1997; 3 N Galldiks (4207_CR51) 2015; 17 R Boellaard (4207_CR6) 2015; 42 P Fragoso Costa (4207_CR11) 2017; 44 M Unterrainer (4207_CR28) 2017; 7 E Lopci (4207_CR89) 2014; 33 S Mattsson (4207_CR95) 2015; 44 CP Filss (4207_CR44) 2017; 7 C Brendle (4207_CR23) 2015; 50 G Lucignani (4207_CR31) 1993; 34 D Salber (4207_CR82) 2006; 33 N Galldiks (4207_CR49) 2010; 37 F Imani (4207_CR66) 2014; 83 O Witte De (4207_CR62) 2000; 49 OL Munk (4207_CR26) 2017; 4 AR Zazulia (4207_CR80) 2009; 40 S Minoshima (4207_CR27) 1993; 34 A Varrone (4207_CR13) 2009; 36 T Nihashi (4207_CR67) 2013; 34 S Dethy (4207_CR73) 1995; 97 L Novak (4207_CR90) 2005; 53 S Bette (4207_CR43) 2016; 89 CN Ladefoged (4207_CR20) 2017; 147 30685796 - Eur J Nucl Med Mol Imaging. 2019 May;46(5):1051-1053 |
| References_xml | – volume: 2 start-page: 8 year: 2015 ident: CR22 article-title: Dental artifacts in the head and neck region: implications for Dixon-based attenuation correction in PET/MR publication-title: EJNMMI Phys doi: 10.1186/s40658-015-0112-5 – volume: 34 start-page: 796 year: 2007 end-page: 798 ident: CR15 article-title: The new EANM paediatric dosage card publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-007-0370-0 – volume: 1 start-page: 101 year: 2014 ident: CR21 article-title: Impact of incorrect tissue classification in Dixon-based MR-AC: fat-water tissue inversion publication-title: EJNMMI Phys doi: 10.1186/s40658-014-0101-0 – volume: 36 start-page: 2103 year: 2009 end-page: 2110 ident: CR13 article-title: EANM procedure guidelines for PET brain imaging using [(18)F]FDG, version 2 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-009-1264-0 – volume: 42 start-page: 685 year: 2015 end-page: 695 ident: CR55 article-title: Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[(18)F]fluoroethyl)-L-tyrosine PET publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-014-2959-4 – volume: 53 start-page: 112 year: 2005 end-page: 114 ident: CR90 article-title: Does increased 18FDG uptake reflect malignant transformation of a low-grade glioma? A diagnostic dilemma publication-title: Neurol India doi: 10.4103/0028-3886.15076 – volume: 16 start-page: 603 year: 2014 end-page: 609 ident: CR53 article-title: Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients publication-title: Neuro Oncol doi: 10.1093/neuonc/not166 – volume: 10 start-page: 423 year: 2015 end-page: 430 ident: CR71 article-title: (18)F-Flourodeoxy-glucose PET/computed tomography in brain tumors: value to patient management and survival outcomes publication-title: PET Clin doi: 10.1016/j.cpet.2015.03.011 – volume: 26 start-page: 159 year: 2013 end-page: 171 ident: CR93 article-title: Physical and organizational provision for installation, regulatory requirements and implementation of a simultaneous hybrid PET/MR-imaging system in an integrated research and clinical setting publication-title: MAGMA doi: 10.1007/s10334-012-0347-2 – volume: 43 start-page: 1157 year: 2002 end-page: 1166 ident: CR30 article-title: The FDG lumped constant in normal human brain publication-title: J Nucl Med – volume: 53 start-page: 1048 year: 2012 end-page: 1057 ident: CR57 article-title: Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI publication-title: J Nucl Med doi: 10.2967/jnumed.111.098590 – volume: 10 start-page: 1 year: 2008 end-page: 18 ident: CR86 article-title: 11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas publication-title: Mol Imaging Biol doi: 10.1007/s11307-007-0115-2 – ident: CR12 – volume: 83 start-page: e100 year: 2014 end-page: e105 ident: CR66 article-title: Molecular and metabolic pattern classification for detection of brain glioma progression publication-title: Eur J Radiol doi: 10.1016/j.ejrad.2013.06.033 – volume: 58 start-page: 129 year: 2017 end-page: 137 ident: CR88 article-title: Epileptic activity increases cerebral amino acid transport assessed by [18F]-fluoroethyl-L-tyrosine amino acid PET: a potential brain tumor mimic publication-title: J Nucl Med doi: 10.2967/jnumed.116.176610 – volume: 20 start-page: 3550 year: 2014 end-page: 3559 ident: CR29 article-title: Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-13-1440 – volume: 34 start-page: 85 year: 2013 end-page: 91 ident: CR39 article-title: 11C-Methionine uptake correlates with combined 1p and 19q loss of heterozygosity in oligodendroglial tumors publication-title: AJNR Am J Neuroradiol doi: 10.3174/ajnr.A3173 – volume: 33 start-page: 1029 year: 2006 end-page: 1035 ident: CR82 article-title: Differential uptake of [18F]FET and [3H]l-methionine in focal cortical ischemia publication-title: Nucl Med Biol doi: 10.1016/j.nucmedbio.2006.09.004 – volume: 44 start-page: 7 year: 2015 end-page: 321 ident: CR95 article-title: Radiation dose to patients from radiopharmaceuticals: a compendium of current information related to frequently used substances publication-title: Ann ICRP doi: 10.1177/0146645314558019 – volume: 44 start-page: 1604 year: 2017 end-page: 1606 ident: CR11 article-title: An insight into the EANM Technologist Committee benchmark document on nuclear medicine technologists’ competencies publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-017-3741-1 – volume: 41 start-page: e351 year: 2016 end-page: e352 ident: CR84 article-title: 18F-DOPA uptake of developmental venous anomalies in children with brain tumors publication-title: Clin Nucl Med doi: 10.1097/RLU.0000000000001189 – volume: 34 start-page: 360 year: 1993 end-page: 369 ident: CR31 article-title: Measurement of regional cerebral glucose utilization with fluorine-18-FDG and PET in heterogeneous tissues: theoretical considerations and practical procedure publication-title: J Nucl Med – volume: 37 start-page: 1521 year: 2010 end-page: 1528 ident: CR75 article-title: Is there a place for FET PET in the initial evaluation of brain lesions with unknown significance? publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-010-1457-6 – volume: 44 start-page: 1223 year: 2017 end-page: 1233 ident: CR25 article-title: Clinical evaluation of TOF versus non-TOF on PET artifacts in simultaneous PET/MR: a dual centre experience publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-017-3619-2 – volume: 4 start-page: 5 year: 2017 ident: CR26 article-title: Point-spread function reconstructed PET images of sub-centimeter lesions are not quantitative publication-title: EJNMMI Phys doi: 10.1186/s40658-016-0169-9 – volume: 20 start-page: 279 year: 2018 end-page: 288 ident: CR35 article-title: Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma publication-title: Neuro Oncol doi: 10.1093/neuonc/nox153 – volume: 34 start-page: 322 year: 1993 end-page: 329 ident: CR27 article-title: Automated detection of the intercommissural line for stereotactic localization of functional brain images publication-title: J Nucl Med – volume: 54 start-page: 229 year: 2013 end-page: 235 ident: CR45 article-title: Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma publication-title: J Nucl Med doi: 10.2967/jnumed.112.109603 – volume: 54 start-page: 2046 year: 2013 end-page: 2054 ident: CR54 article-title: Role of O-(2-18F-fluoroethyl)-L-tyrosine PET as a diagnostic tool for detection of malignant progression in patients with low-grade glioma publication-title: J Nucl Med doi: 10.2967/jnumed.113.123836 – volume: 36 start-page: 2175 year: 1995 end-page: 2179 ident: CR77 article-title: Carbon-11-methionine PET evaluation of intracerebral hematoma: distinguishing neoplastic from non-neoplastic hematoma publication-title: J Nucl Med – volume: 104 start-page: 78 year: 2012 end-page: 82 ident: CR40 article-title: FET-PET assessed recurrence pattern after radio-chemotherapy in newly diagnosed patients with glioblastoma is influenced by MGMT methylation status publication-title: Radiother Oncol doi: 10.1016/j.radonc.2012.04.022 – volume: 200 start-page: W654 year: 2013 end-page: W660 ident: CR68 article-title: PET in the clinical management of glioma: evidence map publication-title: AJR Am J Roentgenol doi: 10.2214/AJR.12.9168 – volume: 49 start-page: 157 year: 2000 end-page: 163 ident: CR62 article-title: FDG-PET as a prognostic factor in high-grade astrocytoma publication-title: J Neurooncol doi: 10.1023/A:1026518002800 – volume: 40 start-page: 1781 year: 2013 end-page: 1783 ident: CR94 article-title: Suggested pathway to assess radiation safety of 18F-labeled PET tracers for first-in-human studies publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-013-2512-x – volume: 50 start-page: 339 year: 2015 end-page: 346 ident: CR23 article-title: Segmentation-based attenuation correction in positron emission tomography/magnetic resonance: erroneous tissue identification and its impact on positron emission tomography interpretation publication-title: Invest Radiol doi: 10.1097/RLI.0000000000000131 – volume: 34 start-page: 944 year: 2013 end-page: 950 ident: CR67 article-title: Diagnostic accuracy of PET for recurrent glioma diagnosis: a meta-analysis publication-title: AJNR Am J Neuroradiol doi: 10.3174/ajnr.A3324 – volume: 13 start-page: 279 year: 2017 end-page: 289 ident: CR8 article-title: Advances in neuro-oncology imaging publication-title: Nat Rev Neurol doi: 10.1038/nrneurol.2017.44 – volume: 7 start-page: 48 year: 2017 ident: CR28 article-title: Towards standardization of (18)F-FET PET imaging: do we need a consistent method of background activity assessment publication-title: EJNMMI Res doi: 10.1186/s13550-017-0295-y – volume: 14 start-page: 1473 year: 2012 end-page: 1480 ident: CR36 article-title: Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas publication-title: Neuro Oncol doi: 10.1093/neuonc/nos259 – volume: 89 start-page: 230 year: 2016 end-page: 239 ident: CR43 article-title: Prognostic value of O-(2-[18F]-fluoroethyl)-L-tyrosine-positron emission tomography imaging for histopathologic characteristics and progression-free survival in patients with low-grade glioma publication-title: World Neurosurg doi: 10.1016/j.wneu.2016.01.085 – volume: 57 start-page: 918 year: 2016 end-page: 924 ident: CR16 article-title: Dixon sequence with superimposed model-based bone compartment provides highly accurate PET/MR attenuation correction of the brain publication-title: J Nucl Med doi: 10.2967/jnumed.115.166967 – volume: 48 start-page: 1468 year: 2007 end-page: 1481 ident: CR70 article-title: Clinical applications of PET in brain tumors publication-title: J Nucl Med doi: 10.2967/jnumed.106.037689 – volume: 26 start-page: 1363 year: 1999 end-page: 1378 ident: CR72 article-title: Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine publication-title: Eur J Nucl Med doi: 10.1007/s002590050597 – volume: 42 start-page: 328 year: 2015 end-page: 354 ident: CR6 article-title: FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-014-2961-x – volume: 49 start-page: 694 year: 2008 end-page: 699 ident: CR52 article-title: Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy publication-title: J Nucl Med doi: 10.2967/jnumed.107.048082 – volume: 15 start-page: 1058 year: 2013 end-page: 1067 ident: CR50 article-title: Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study publication-title: Neuro Oncol doi: 10.1093/neuonc/not002 – volume: 36 start-page: 211 year: 2015 end-page: 218 ident: CR42 article-title: 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography in relation to methyl-guanine methyltransferase promoter methylation in high-grade gliomas publication-title: Nucl Med Commun doi: 10.1097/MNM.0000000000000236 – volume: 125 start-page: 167 year: 2015 end-page: 175 ident: CR65 article-title: The use of (18)F-FDG PET to differentiate progressive disease from treatment induced necrosis in high grade glioma publication-title: J Neurooncol doi: 10.1007/s11060-015-1883-1 – volume: 37 start-page: 181 year: 2010 end-page: 200 ident: CR91 article-title: FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-009-1297-4 – volume: 25 start-page: 3017 year: 2015 end-page: 3024 ident: CR47 article-title: Dual-time-point O-(2-[F]fluoroethyl)-L-tyrosine PET for grading of cerebral gliomas publication-title: Eur Radiol doi: 10.1007/s00330-015-3691-6 – volume: 51 start-page: 790 year: 2010 end-page: 797 ident: CR79 article-title: Comparison of O-(2-18F-fluoroethyl)-L-tyrosine and L-3H-methionine uptake in cerebral hematomas publication-title: J Nucl Med doi: 10.2967/jnumed.109.071423 – volume: 12 start-page: 137 year: 2013 end-page: 147 ident: CR87 article-title: [18F]fluoroethyltyrosine-positron emission tomography-based therapy monitoring after stereotactic iodine-125 brachytherapy in patients with recurrent high-grade glioma publication-title: Mol Imaging doi: 10.2310/7290.2012.00027 – volume: 17 start-page: 1293 year: 2015 end-page: 1300 ident: CR51 article-title: The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma publication-title: Neuro Oncol doi: 10.1093/neuonc/nov118 – volume: 26 start-page: 1859 year: 1995 end-page: 1866 ident: CR81 article-title: Amino acid uptake in ischemically compromised brain tissue publication-title: Stroke doi: 10.1161/01.STR.26.10.1859 – start-page: 218 year: 2015 end-page: 229 ident: CR83 article-title: Pediatric hybrid imaging of the brain publication-title: Clinical molecular anatomic imaging - PET/CT, PET/MR and SPECT/CT – volume: 50 start-page: 167 year: 2011 end-page: 173 ident: CR96 article-title: German guidelines for brain tumour imaging by PET and SPECT using labelled amino acids publication-title: Nuklearmedizin doi: 10.3413/Nukmed-0347-10-09 – volume: 18 start-page: e315 year: 2017 end-page: e329 ident: CR2 article-title: European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas publication-title: Lancet Oncol doi: 10.1016/S1470-2045(17)30194-8 – ident: CR14 – volume: 14 start-page: 649 year: 2012 end-page: 657 ident: CR61 article-title: FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan publication-title: Neuro Oncol doi: 10.1093/neuonc/nos012 – ident: CR37 – volume: 40 start-page: 1638 year: 2009 end-page: 1643 ident: CR80 article-title: Transient focal increase in perihematomal glucose metabolism after acute human intracerebral hemorrhage publication-title: Stroke doi: 10.1161/STROKEAHA.108.536037 – volume: 17 start-page: 47 year: 2003 end-page: 51 ident: CR76 article-title: Evaluation of treatment effects in brain abscess with positron emission tomography: comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine publication-title: Ann Nucl Med doi: 10.1007/BF02988258 – volume: 147 start-page: 346 year: 2017 end-page: 359 ident: CR20 article-title: A multi-centre evaluation of eleven clinically feasible brain PET/MRI attenuation correction techniques using a large cohort of patients publication-title: Neuroimage doi: 10.1016/j.neuroimage.2016.12.010 – volume: 28 start-page: 1963 year: 2010 end-page: 1972 ident: CR5 article-title: Updated response assessment criteria for high-grade gliomas: Response Assessment in Neuro-Oncology Working Group publication-title: J Clin Oncol doi: 10.1200/JCO.2009.26.3541 – volume: 16 start-page: e534 year: 2015 end-page: e542 ident: CR4 article-title: Immunotherapy response assessment in neuro-oncology: a report of the RANO working group publication-title: Lancet Oncol doi: 10.1016/S1470-2045(15)00088-1 – volume: 7 start-page: 64 year: 2017 ident: CR44 article-title: O-(2-[(18)F]fluoroethyl)-L-tyrosine PET in gliomas: influence of data processing in different centres publication-title: EJNMMI Res doi: 10.1186/s13550-017-0316-x – volume: 97 start-page: 349 year: 1995 end-page: 353 ident: CR73 article-title: PET findings in a brain abscess associated with a silent atrial septal defect publication-title: Clin Neurol Neurosurg doi: 10.1016/0303-8467(95)00067-T – volume: 11 start-page: 453 year: 2017 ident: CR18 article-title: RESOLUTE PET/MRI attenuation correction for O-(2-18F-fluoroethyl)-L-tyrosine (FET) in brain tumor patients with metal implants publication-title: Front Neurosci doi: 10.3389/fnins.2017.00453 – volume: 37 start-page: 662 year: 2010 end-page: 671 ident: CR92 article-title: Routine quality control recommendations for nuclear medicine instrumentation publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-009-1347-y – volume: 17 start-page: iv1 issue: Suppl 4 year: 2015 end-page: iv62 ident: CR1 article-title: CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012 publication-title: Neuro Oncol doi: 10.1093/neuonc/nov189 – ident: CR63 – volume: 58 start-page: 840 year: 2017 end-page: 845 ident: CR24 article-title: PET/MRI in the presence of metal implants: completion of the attenuation map from PET emission data publication-title: J Nucl Med doi: 10.2967/jnumed.116.183343 – volume: 52 start-page: 856 year: 2011 end-page: 864 ident: CR58 article-title: O-(2-18F-fluoroethyl)-L-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma publication-title: J Nucl Med doi: 10.2967/jnumed.110.086645 – volume: 35 start-page: 1162 year: 1994 end-page: 1166 ident: CR78 article-title: Carbon-11-methionine and fluorine-18-FDG PET study in brain hematoma publication-title: J Nucl Med – volume: 84 start-page: 206 year: 2014 end-page: 216 ident: CR19 article-title: Combined PET/MR imaging in neurology: MR-based attenuation correction implies a strong spatial bias when ignoring bone publication-title: Neuroimage doi: 10.1016/j.neuroimage.2013.08.042 – volume: 125 start-page: 212 year: 2014 end-page: 216 ident: CR41 article-title: (11)C-methinine uptake correlates with MGMT promoter methylation in nonenhancing gliomas publication-title: Clin Neurol Neurosurg doi: 10.1016/j.clineuro.2014.08.004 – volume: 38 start-page: 495 year: 2013 end-page: 500 ident: CR64 article-title: Validation of 18F-FDG PET at conventional and delayed intervals for the discrimination of high-grade from low-grade gliomas: a stereotactic PET and MRI study publication-title: Clin Nucl Med doi: 10.1097/RLU.0b013e318292a753 – volume: 18 start-page: 1199 year: 2016 end-page: 1208 ident: CR7 article-title: Response Assessment in Neuro-Oncology Working Group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas publication-title: Neuro Oncol doi: 10.1093/neuonc/now058 – volume: 37 start-page: 84 year: 2010 end-page: 92 ident: CR49 article-title: Volumetry of [(11)C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-009-1219-5 – volume: 81 start-page: 508 year: 2012 end-page: 513 ident: CR69 article-title: F-18 FDG PET-CT in patients with recurrent glioma: comparison with contrast enhanced MRI publication-title: Eur J Radiol doi: 10.1016/j.ejrad.2011.01.080 – volume: 47 start-page: 776 year: 2006 end-page: 782 ident: CR74 article-title: 18F-FET PET differentiation of ring-enhancing brain lesions publication-title: J Nucl Med – volume: 3 start-page: 8 year: 1997 end-page: 17 ident: CR85 article-title: Positron emission tomography, magnetic resonance imaging and proton NMR spectroscopy of white matter in multiple sclerosis publication-title: Mult Scler doi: 10.1177/135245859700300102 – volume: 16 start-page: vii24 issue: Suppl 7 year: 2014 end-page: vii35 ident: CR3 article-title: Impact of imaging measurements on response assessment in glioblastoma clinical trials publication-title: Neuro Oncol doi: 10.1093/neuonc/nou286 – volume: 33 start-page: 1374 year: 2006 end-page: 1380 ident: CR10 article-title: EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-006-0206-3 – volume: 128 start-page: 678 year: 2005 end-page: 687 ident: CR32 article-title: O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas publication-title: Brain doi: 10.1093/brain/awh399 – volume: 131 start-page: 803 year: 2016 end-page: 820 ident: CR34 article-title: The 2016 World Health Organization classification of tumors of the central nervous system: a summary publication-title: Acta Neuropathol doi: 10.1007/s00401-016-1545-1 – volume: 44 start-page: 1155 year: 2017 end-page: 1164 ident: CR38 article-title: Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-017-3618-3 – volume: 43 start-page: 1105 year: 2016 end-page: 1114 ident: CR48 article-title: Early static F-FET-PET scans have a higher accuracy for glioma grading than the standard 20-40 min scans publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-015-3276-2 – volume: 22 start-page: 2190 year: 2016 end-page: 2196 ident: CR56 article-title: Late pseudoprogression in glioblastoma: diagnostic value of dynamic O-(2-[18F]fluoroethyl)-L-tyrosine PET publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-15-1334 – volume: 33 start-page: 234 year: 2014 end-page: 236 ident: CR89 article-title: (11)C-methionine uptake in secondary brain epilepsy publication-title: Rev Esp Med Nucl Imagen Mol – volume: 40 start-page: 22 year: 2013 end-page: 33 ident: CR59 article-title: Response assessment of bevacizumab in patients with recurrent malignant glioma using [(18)F]fluoroethyl-L-tyrosine PET in comparison to MRI publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-012-2251-4 – volume: 20 start-page: 4 year: 2018 end-page: 20 ident: CR17 article-title: Combined PET/MRI: global warming—summary report of the 6th International Workshop on PET/MRI, March 27-29, 2017, Tübingen, Germany publication-title: Mol Imaging Biol doi: 10.1007/s11307-017-1123-5 – volume: 50 start-page: 1316 year: 1998 end-page: 1322 ident: CR46 article-title: 11C-methionine PET for differential diagnosis of low-grade gliomas publication-title: Neurology doi: 10.1212/WNL.50.5.1316 – volume: 12 start-page: 375 year: 2016 end-page: 376 ident: CR9 article-title: Neuro-oncology: amino acid PET for brain tumours - ready for the clinic publication-title: Nat Rev Neurol doi: 10.1038/nrneurol.2016.80 – volume: 10 start-page: 7163 year: 2004 end-page: 7170 ident: CR33 article-title: Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-04-0262 – volume: 33 start-page: 516 year: 2006 end-page: 524 ident: CR60 article-title: Use of (11)C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-005-0002-5 – volume: 16 start-page: 603 year: 2014 ident: 4207_CR53 publication-title: Neuro Oncol doi: 10.1093/neuonc/not166 – volume: 42 start-page: 328 year: 2015 ident: 4207_CR6 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-014-2961-x – volume: 41 start-page: e351 year: 2016 ident: 4207_CR84 publication-title: Clin Nucl Med doi: 10.1097/RLU.0000000000001189 – volume: 34 start-page: 322 year: 1993 ident: 4207_CR27 publication-title: J Nucl Med – volume: 20 start-page: 3550 year: 2014 ident: 4207_CR29 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-13-1440 – volume: 10 start-page: 7163 year: 2004 ident: 4207_CR33 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-04-0262 – volume: 17 start-page: 1293 year: 2015 ident: 4207_CR51 publication-title: Neuro Oncol doi: 10.1093/neuonc/nov118 – volume: 33 start-page: 1374 year: 2006 ident: 4207_CR10 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-006-0206-3 – volume: 38 start-page: 495 year: 2013 ident: 4207_CR64 publication-title: Clin Nucl Med doi: 10.1097/RLU.0b013e318292a753 – volume: 40 start-page: 1781 year: 2013 ident: 4207_CR94 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-013-2512-x – volume: 97 start-page: 349 year: 1995 ident: 4207_CR73 publication-title: Clin Neurol Neurosurg doi: 10.1016/0303-8467(95)00067-T – volume: 33 start-page: 516 year: 2006 ident: 4207_CR60 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-005-0002-5 – volume: 48 start-page: 1468 year: 2007 ident: 4207_CR70 publication-title: J Nucl Med doi: 10.2967/jnumed.106.037689 – volume: 7 start-page: 48 year: 2017 ident: 4207_CR28 publication-title: EJNMMI Res doi: 10.1186/s13550-017-0295-y – volume: 50 start-page: 167 year: 2011 ident: 4207_CR96 publication-title: Nuklearmedizin doi: 10.3413/Nukmed-0347-10-09 – volume: 26 start-page: 1859 year: 1995 ident: 4207_CR81 publication-title: Stroke doi: 10.1161/01.STR.26.10.1859 – ident: 4207_CR37 doi: 10.1007/s00259-017-3846-6 – volume: 54 start-page: 229 year: 2013 ident: 4207_CR45 publication-title: J Nucl Med doi: 10.2967/jnumed.112.109603 – volume: 58 start-page: 129 year: 2017 ident: 4207_CR88 publication-title: J Nucl Med doi: 10.2967/jnumed.116.176610 – volume: 7 start-page: 64 year: 2017 ident: 4207_CR44 publication-title: EJNMMI Res doi: 10.1186/s13550-017-0316-x – volume: 36 start-page: 2103 year: 2009 ident: 4207_CR13 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-009-1264-0 – volume: 49 start-page: 157 year: 2000 ident: 4207_CR62 publication-title: J Neurooncol doi: 10.1023/A:1026518002800 – volume: 51 start-page: 790 year: 2010 ident: 4207_CR79 publication-title: J Nucl Med doi: 10.2967/jnumed.109.071423 – volume: 12 start-page: 137 year: 2013 ident: 4207_CR87 publication-title: Mol Imaging doi: 10.2310/7290.2012.00027 – volume: 3 start-page: 8 year: 1997 ident: 4207_CR85 publication-title: Mult Scler doi: 10.1177/135245859700300102 – volume: 28 start-page: 1963 year: 2010 ident: 4207_CR5 publication-title: J Clin Oncol doi: 10.1200/JCO.2009.26.3541 – volume: 43 start-page: 1157 year: 2002 ident: 4207_CR30 publication-title: J Nucl Med – volume: 104 start-page: 78 year: 2012 ident: 4207_CR40 publication-title: Radiother Oncol doi: 10.1016/j.radonc.2012.04.022 – volume: 16 start-page: vii24 issue: Suppl 7 year: 2014 ident: 4207_CR3 publication-title: Neuro Oncol doi: 10.1093/neuonc/nou286 – volume: 50 start-page: 339 year: 2015 ident: 4207_CR23 publication-title: Invest Radiol doi: 10.1097/RLI.0000000000000131 – volume: 17 start-page: 47 year: 2003 ident: 4207_CR76 publication-title: Ann Nucl Med doi: 10.1007/BF02988258 – volume: 17 start-page: iv1 issue: Suppl 4 year: 2015 ident: 4207_CR1 publication-title: Neuro Oncol doi: 10.1093/neuonc/nov189 – volume: 10 start-page: 1 year: 2008 ident: 4207_CR86 publication-title: Mol Imaging Biol doi: 10.1007/s11307-007-0115-2 – volume: 54 start-page: 2046 year: 2013 ident: 4207_CR54 publication-title: J Nucl Med doi: 10.2967/jnumed.113.123836 – volume: 49 start-page: 694 year: 2008 ident: 4207_CR52 publication-title: J Nucl Med doi: 10.2967/jnumed.107.048082 – volume: 200 start-page: W654 year: 2013 ident: 4207_CR68 publication-title: AJR Am J Roentgenol doi: 10.2214/AJR.12.9168 – ident: 4207_CR12 – volume: 44 start-page: 1223 year: 2017 ident: 4207_CR25 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-017-3619-2 – volume: 26 start-page: 1363 year: 1999 ident: 4207_CR72 publication-title: Eur J Nucl Med doi: 10.1007/s002590050597 – volume: 36 start-page: 2175 year: 1995 ident: 4207_CR77 publication-title: J Nucl Med – volume: 2 start-page: 8 year: 2015 ident: 4207_CR22 publication-title: EJNMMI Phys doi: 10.1186/s40658-015-0112-5 – volume: 14 start-page: 1473 year: 2012 ident: 4207_CR36 publication-title: Neuro Oncol doi: 10.1093/neuonc/nos259 – volume: 44 start-page: 1155 year: 2017 ident: 4207_CR38 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-017-3618-3 – volume: 4 start-page: 5 year: 2017 ident: 4207_CR26 publication-title: EJNMMI Phys doi: 10.1186/s40658-016-0169-9 – volume: 37 start-page: 84 year: 2010 ident: 4207_CR49 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-009-1219-5 – volume: 22 start-page: 2190 year: 2016 ident: 4207_CR56 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-15-1334 – volume: 34 start-page: 796 year: 2007 ident: 4207_CR15 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-007-0370-0 – volume: 34 start-page: 85 year: 2013 ident: 4207_CR39 publication-title: AJNR Am J Neuroradiol doi: 10.3174/ajnr.A3173 – volume: 43 start-page: 1105 year: 2016 ident: 4207_CR48 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-015-3276-2 – volume: 40 start-page: 22 year: 2013 ident: 4207_CR59 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-012-2251-4 – volume: 125 start-page: 212 year: 2014 ident: 4207_CR41 publication-title: Clin Neurol Neurosurg doi: 10.1016/j.clineuro.2014.08.004 – volume: 53 start-page: 112 year: 2005 ident: 4207_CR90 publication-title: Neurol India doi: 10.4103/0028-3886.15076 – volume: 10 start-page: 423 year: 2015 ident: 4207_CR71 publication-title: PET Clin doi: 10.1016/j.cpet.2015.03.011 – volume: 1 start-page: 101 year: 2014 ident: 4207_CR21 publication-title: EJNMMI Phys doi: 10.1186/s40658-014-0101-0 – volume: 37 start-page: 181 year: 2010 ident: 4207_CR91 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-009-1297-4 – volume: 44 start-page: 1604 year: 2017 ident: 4207_CR11 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-017-3741-1 – volume: 89 start-page: 230 year: 2016 ident: 4207_CR43 publication-title: World Neurosurg doi: 10.1016/j.wneu.2016.01.085 – volume: 33 start-page: 234 year: 2014 ident: 4207_CR89 publication-title: Rev Esp Med Nucl Imagen Mol – ident: 4207_CR63 doi: 10.1093/neuonc/nov148 – volume: 42 start-page: 685 year: 2015 ident: 4207_CR55 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-014-2959-4 – volume: 14 start-page: 649 year: 2012 ident: 4207_CR61 publication-title: Neuro Oncol doi: 10.1093/neuonc/nos012 – volume: 35 start-page: 1162 year: 1994 ident: 4207_CR78 publication-title: J Nucl Med – volume: 16 start-page: e534 year: 2015 ident: 4207_CR4 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(15)00088-1 – volume: 125 start-page: 167 year: 2015 ident: 4207_CR65 publication-title: J Neurooncol doi: 10.1007/s11060-015-1883-1 – volume: 40 start-page: 1638 year: 2009 ident: 4207_CR80 publication-title: Stroke doi: 10.1161/STROKEAHA.108.536037 – volume: 50 start-page: 1316 year: 1998 ident: 4207_CR46 publication-title: Neurology doi: 10.1212/WNL.50.5.1316 – volume: 26 start-page: 159 year: 2013 ident: 4207_CR93 publication-title: MAGMA doi: 10.1007/s10334-012-0347-2 – volume: 53 start-page: 1048 year: 2012 ident: 4207_CR57 publication-title: J Nucl Med doi: 10.2967/jnumed.111.098590 – volume: 12 start-page: 375 year: 2016 ident: 4207_CR9 publication-title: Nat Rev Neurol doi: 10.1038/nrneurol.2016.80 – volume: 83 start-page: e100 year: 2014 ident: 4207_CR66 publication-title: Eur J Radiol doi: 10.1016/j.ejrad.2013.06.033 – volume: 25 start-page: 3017 year: 2015 ident: 4207_CR47 publication-title: Eur Radiol doi: 10.1007/s00330-015-3691-6 – volume: 18 start-page: 1199 year: 2016 ident: 4207_CR7 publication-title: Neuro Oncol doi: 10.1093/neuonc/now058 – volume: 128 start-page: 678 year: 2005 ident: 4207_CR32 publication-title: Brain doi: 10.1093/brain/awh399 – volume: 18 start-page: e315 year: 2017 ident: 4207_CR2 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(17)30194-8 – volume: 57 start-page: 918 year: 2016 ident: 4207_CR16 publication-title: J Nucl Med doi: 10.2967/jnumed.115.166967 – volume: 37 start-page: 662 year: 2010 ident: 4207_CR92 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-009-1347-y – volume: 44 start-page: 7 year: 2015 ident: 4207_CR95 publication-title: Ann ICRP doi: 10.1177/0146645314558019 – volume: 147 start-page: 346 year: 2017 ident: 4207_CR20 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2016.12.010 – volume: 131 start-page: 803 year: 2016 ident: 4207_CR34 publication-title: Acta Neuropathol doi: 10.1007/s00401-016-1545-1 – volume: 36 start-page: 211 year: 2015 ident: 4207_CR42 publication-title: Nucl Med Commun doi: 10.1097/MNM.0000000000000236 – volume: 58 start-page: 840 year: 2017 ident: 4207_CR24 publication-title: J Nucl Med doi: 10.2967/jnumed.116.183343 – volume: 11 start-page: 453 year: 2017 ident: 4207_CR18 publication-title: Front Neurosci doi: 10.3389/fnins.2017.00453 – volume: 34 start-page: 360 year: 1993 ident: 4207_CR31 publication-title: J Nucl Med – ident: 4207_CR14 – volume: 15 start-page: 1058 year: 2013 ident: 4207_CR50 publication-title: Neuro Oncol doi: 10.1093/neuonc/not002 – volume: 84 start-page: 206 year: 2014 ident: 4207_CR19 publication-title: Neuroimage doi: 10.1016/j.neuroimage.2013.08.042 – volume: 20 start-page: 279 year: 2018 ident: 4207_CR35 publication-title: Neuro Oncol doi: 10.1093/neuonc/nox153 – volume: 34 start-page: 944 year: 2013 ident: 4207_CR67 publication-title: AJNR Am J Neuroradiol doi: 10.3174/ajnr.A3324 – volume: 13 start-page: 279 year: 2017 ident: 4207_CR8 publication-title: Nat Rev Neurol doi: 10.1038/nrneurol.2017.44 – volume: 37 start-page: 1521 year: 2010 ident: 4207_CR75 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-010-1457-6 – volume: 47 start-page: 776 year: 2006 ident: 4207_CR74 publication-title: J Nucl Med – start-page: 218 volume-title: Clinical molecular anatomic imaging - PET/CT, PET/MR and SPECT/CT year: 2015 ident: 4207_CR83 – volume: 33 start-page: 1029 year: 2006 ident: 4207_CR82 publication-title: Nucl Med Biol doi: 10.1016/j.nucmedbio.2006.09.004 – volume: 52 start-page: 856 year: 2011 ident: 4207_CR58 publication-title: J Nucl Med doi: 10.2967/jnumed.110.086645 – volume: 81 start-page: 508 year: 2012 ident: 4207_CR69 publication-title: Eur J Radiol doi: 10.1016/j.ejrad.2011.01.080 – volume: 20 start-page: 4 year: 2018 ident: 4207_CR17 publication-title: Mol Imaging Biol doi: 10.1007/s11307-017-1123-5 – reference: 30685796 - Eur J Nucl Med Mol Imaging. 2019 May;46(5):1051-1053 |
| SSID | ssj0018289 |
| Score | 2.6784773 |
| Snippet | These joint practice guidelines, or procedure standards, were developed collaboratively by the European Association of Nuclear Medicine (EANM), the Society of... |
| SourceID | pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 540 |
| SubjectTerms | Adult Amino Acids Brain Cardiology Child Clinical practice guidelines Diagnostic systems Fluorodeoxyglucose F18 Glioma Glioma - diagnostic imaging Guidelines Humans Image Processing, Computer-Assisted Imaging Isotope Labeling Magnetic resonance imaging Medical imaging Medicine Medicine & Public Health Neuroimaging Nuclear Medicine Oncology Orthopedics Patients Positron emission Positron emission tomography Positron-Emission Tomography - standards Practice Guidelines as Topic Quality Control Radiology Recurrence Reference Standards Research Design Societies, Medical Tomography Working groups |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4t1AQXPgBDKbxF7H4YIq2KVU2gVBK62EUGTHzhKpTco--DX8WGbyqpaKXnKJ7Viaieebh79h7KU3yhap8Dx3znGptOLWCMvTpMidNkJ4TwH92VwdncrjxXjRBdzWXVllfyY2B7Wrc4qRj9A0Edl5nOp3F784dY2i7GrXQuMmuxUhEqHWDclicLgi8ibI4UIngSeo231WM2xIRBH4oyOtuYzDhKe7dukK2LxaM_lP4rSxR9N77G4HJOGwlfx9dsNXD9jtWZcqf8j-HNdltYHJ4Xw2wsfn0Vd8QH8pCpZb4reimvfRt_ls9gkaS-a2Kw99dGENCGihPG_6GEFdwPKspGoioFr5JXyZnABFcWFlXIkOMmUwvANzXlY1mLzE-bgOfI_09Mf0w8e38LsNzUH0JnzETqeTk_dHvGvFwHOpxxseSy1UHkqD3lPknVShR1yl48TGxijhEtSFQhnjpBe5sy62hi4AycgX1qQiEo_ZXlVXfp9Bqixqh7ZonI2kJJ_zaTQuRJwap6W3AQt7QWR5x1NO7TLOsoFhuZFdhrLLSHZZGrBXw5SLlqTjusEHvXSz7n9dZ5faFbAnraCHlQShXK2SgCU7KjAMIIbu3TdV-bNh6kY0h4hKBOx1ryyXn_zvBp9ev8Fn7A6CtrStgztge5vV1j9HYLSxLxrt_wvc2Qqn priority: 102 providerName: ProQuest |
| Title | Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0 |
| URI | https://link.springer.com/article/10.1007/s00259-018-4207-9 https://www.ncbi.nlm.nih.gov/pubmed/30519867 https://www.proquest.com/docview/2150236298 https://pubmed.ncbi.nlm.nih.gov/PMC6351513 |
| Volume | 46 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb9MwFLbYJiFeEHcCozoPPIFMm9h1HN7a0mxMSpjGJlVCKLJjp0TaUtS1_Bp-LMe5oW6AxIvzENtJdI5zvnPxZ0JeWyV0ETFLc2MM5UIKqhXTNAqL3EjFmLUuoJ-k4viCnyzGi5Ys2u2FuZG_d2SfCNDR4ZWUB6OQRnvkYIz_XafMMzHrEwbOcXC-FfoDNEQ17hKYf5pi1wTdwpW3yyNv5Ehr0xM_IPdbzAiTRsgPyR1bPSJ3kzYr_pj8PFmV1QbmkzQZYvNpeIYNdPufYLl1VFauvH34OU2Sj1AbLbNdW-gCCdeA2BXKq_rIIlgVsLwsXeEQuLL4JZzOz8EFbGGtTIm-sEtWWAPqqqxWoPISx-M88MWX8df4w9F7-NFE4cB_N3pCLuL5-eyYtqcu0JzL8YYGXDKRj7hCR8m3houRRQglg1AHSglmQhR7IZQy3LLcaBNo5fb6cN8WWkXMZ0_JfrWq7HMCkdCoCFKjHVbc5fOMjfxxwYJIGcmt9sioE0SWt5Tk7mSMy6wnU65ll6HsMie7LPLIm37I94aP41-dDzvpZu3SvM4Q4zjWfPwkjzxrBN3PxByglSL0SLijAn0HR8a9e6cqv9Wk3AjcEDwxj7ztlOX3I__6gi_-q_dLcg_hWtRUwB2S_c16a18hJNroAdkLFyG2Mj4akINJPJ2meJ3O09OzQb1QfgGx7ggB |
| linkProvider | Springer Nature |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFD4anQS8IO4UBvgBXkCmSewmDtKEBmtpt6VMo5MmTSjYsVMibcnoBcR_4bfw2zhOk0xlYm97yUtsx9E5tr9z8XcAXhjpqzRkhiZaa8p94VMlmaJhkCZaSMaMsQ79aOQPDvnOUfdoDf7Ud2FsWmW9J5YbtS4S6yPv4NFkyc69ULw7-05t1SgbXa1LaMiqtILeLCnGqosdu-bXTzThZpvDbZT3S8_r98YfBrSqMkATLrpz6nHB_MThEg0D12juOwYhg_AC5UnpMx3gb6a-lJoblmilPSXt3RbumlTJkLkMx70G69w6UFqw_r432j9o4hjWnrEmH5opNMDVVcdVnZLGFE0PNOUF5Z4T0HD1ZLwAdy9mbf4Tui1PxP5tuFVBWbK11L07sGbyu3A9qoL19-D3TpHlc9LbGkUdfHzqHOCD1NeyyGRhGbZs1n3n8yiKhqQ8S_Viakjt35gRhNQkOy0rKZEiJZOTzOYzEZutPyH7vTGxfmQylTpDE93GUIwm8jTLCyKTDPvjOOTYFf0v_e2Pb8mPpXOQuG-c-3B4JWJ6AK28yM0jIKGvUD-FQngguQ0zahO63ZR5odSCG9UGpxZEnFRM6bZgx0nccDyXsotRdrGVXRy24VXT5WxJE3JZ441aunG1Y8zic_1uw8OloJuRmMXZwg_aEKyoQNPAcoSvvsmzbyVXOOJJxHSsDa9rZTn_5H8n-PjyCT6HG4NxtBfvDUe7T-AmQshwmZW3Aa35dGGeIkybq2fVWiDw9aqX319yuU7j |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkSouiDeBAj7ABWQ2ib2Jg4RQxW7abclSQStVqlCwY2eJ1GbLPkD8F34Jv46ZvKqlordecontOJoZ-5s3Ic-tCnQeccsyYwwTgQyYVlyzKMwzIxXn1qJBPxkHO4di96h_tEb-tLkwGFbZnonVQW2mGdrIe3A1YbFzP5K9vAmL2B_E786-M-wghZ7Wtp1GzSJ79tdPUN_mb0cDoPUL34-HB-93WNNhgGVC9hfMF5IHmSsUKAWeNSJwLcAF6YfaVyrgJoRfzAOljLA8M9r4WmFei_BsrlXEPQ7rXiPXQw5yglnq8XbnwUBNBpU9UFBYCHLVelTdqoApKB2gxEsmfDdk0eqdeAHoXozX_MdpW92F8S1yswGxdKvmuttkzZZ3yEbSuOnvkt-706Jc0OHWOOnB42PvEzxom5BFJ0usrYXx9r3P4yQZ0eoWNcuZpa1lY04BTNPitOqhRKc5nZwUGMlEMU5_QveHBxQtyHSmTAHKOXpPrKHqtCinVGUFzId16LEn4y_xYPsN_VGbBan32r1HDq-ESPfJejkt7UNCo0ADZ0oNwEAJdDAaG3n9nPuRMlJY7RC3JUSaNTXSsVXHSdpVd65olwLtUqRdGjnkZTflrC4QctngzZa6aXNWzNNzznbIg5rQ3UocEbYMQoeEKyzQDcDq4KtvyuJbVSUckCSgOe6QVy2znH_yvxt8dPkGn5ENELr0w2i895jcAOwY1eF4m2R9MVvaJ4DPFvppJQiUfL1qyfsLR_hMfw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Joint+EANM%2FEANO%2FRANO+practice+guidelines%2FSNMMI+procedure+standards+for+imaging+of+gliomas+using+PET+with+radiolabelled+amino+acids+and+%5B18F%5DFDG%3A+version+1.0&rft.jtitle=European+journal+of+nuclear+medicine+and+molecular+imaging&rft.au=Law%2C+Ian&rft.au=Albert%2C+Nathalie+L.&rft.au=Arbizu%2C+Javier&rft.au=Boellaard%2C+Ronald&rft.date=2019-03-01&rft.pub=Springer+Berlin+Heidelberg&rft.issn=1619-7070&rft.eissn=1619-7089&rft.volume=46&rft.issue=3&rft.spage=540&rft.epage=557&rft_id=info:doi/10.1007%2Fs00259-018-4207-9&rft.externalDocID=10_1007_s00259_018_4207_9 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1619-7070&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1619-7070&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1619-7070&client=summon |